VASOMOTOR SYMPTOMS (VMS)
Clinical trials for VASOMOTOR SYMPTOMS (VMS) explained in plain language.
Never miss a new study
Get alerted when new VASOMOTOR SYMPTOMS (VMS) trials appear
Sign up with your email to follow new studies for VASOMOTOR SYMPTOMS (VMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for easing menopausal hot flashes in Long-Term trial
Symptom relief CompletedThis study looked at the long-term safety of an experimental drug called MT-8554 for reducing moderate to severe hot flashes in postmenopausal women. A total of 190 women who had already completed a 12-week study of the drug took part. The main goal was to check for side effects …
Matched conditions: VASOMOTOR SYMPTOMS (VMS)
Phase: PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:00 UTC
-
New supplement aims to cool menopausal hot flashes
Symptom relief CompletedThis study tested whether a daily dietary supplement called Bonafide-HF3.0 can reduce hot flashes and night sweats in women aged 40-70. Over 100 participants tracked their symptoms for 4 weeks, with an optional 8-week extension. The goal was to see if the supplement lessens the n…
Matched conditions: VASOMOTOR SYMPTOMS (VMS)
Phase: NA • Sponsor: Bonafide Health • Aim: Symptom relief
Last updated May 11, 2026 20:46 UTC